China Stroke Primary Prevention Trial | Clinical Trial - CSPPT

Description:

The goal of this trial was to assess the efficacy of folic acid supplementation in the primary prevention of stroke in patients with hypertension.

Contribution to the Literature: The CSPPT trial suggests that oral folic acid supplementation with enalapril may be superior to enalapril alone in the primary prevention of stroke in patients with hypertension.